Alerts will be sent to your verified email
Verify Email
ACCENTMIC
|
Accent Microcell
|
Zim Laboratories
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.77 % | 7.41 % | 8.49 % |
|
5yr average Equity Multiplier
|
2.38 | 1.88 | 1.47 |
|
5yr Average Asset Turnover Ratio
|
1.57 | 0.94 | 0.58 |
|
5yr Avg Net Profit Margin
|
6.42 % | 4.15 % | 10.0 % |
|
Price to Book
|
0.0 | 2.16 | 2.66 |
|
P/E
|
19.3 | 44.81 | 79.48 |
|
5yr Avg Cash Conversion Cycle
|
50.97 Days | 37.07 Days | 13.14 Days |
|
Inventory Days
|
74.08 Days | 68.72 Days | 66.66 Days |
|
Days Receivable
|
62.56 Days | 99.71 Days | 122.66 Days |
|
Days Payable
|
79.61 Days | 143.26 Days | 257.34 Days |
|
5yr Average Interest Coverage Ratio
|
11.5 | 3.96 | 10.36 |
|
5yr Avg ROCE
|
25.04 % | 13.52 % | 12.12 % |
|
5yr Avg Operating Profit Margin
|
10.39 % | 12.21 % | 16.84 % |
|
5 yr average Debt to Equity
|
0.61 | 0.39 | 0.14 |
|
5yr CAGR Net Profit
|
44.43 % | 10.7 % | -6.51 % |
|
5yr Average Return on Assets
|
9.28 % | 4.02 % | 5.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.09 % | 33.26 % | 43.16 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.44 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Accent Microcell
|
Zim Laboratories
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|